ValuentumAd

Official PayPal Seal

Valuentum Reports













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Latest Valuentum Commentary

Mar 15, 2013
Intuitive Surgical's Shares Are Slumping Today
The American Congress of OB/GYN's president made some statements questioning the cost effectivness of robotic surgery.
Mar 4, 2013
Will the FDA Crush Intuitive Surgical?
Probably not, but backlash against robotic surgery could be a headwind.
Feb 19, 2013
Dividend Growth Portfolio Holding Medtronic Posts Solid Third Quarter
Medtronic’s third quarter was solid. Free cash flow remains terrific.
Jan 23, 2013
Best Ideas Portfolio Holding Intuitive Surgical Is Surging Today
The bear case fails to materialize at Intuitive Surgical. The company's fourth-quarter performance has sent the shares soaring.
Dec 20, 2012
The Shorts Are Attacking Intuitive Surgical...It's A Small Position for Us
Citron Research released a "short-seller" report on Intuitive Surgical yesterday. We expect the sell-off to continue until perception improves, which it will.
Oct 17, 2012
Intuitive Surgical Posts Strong Results
Intuitive Surgical continues to grow at a healthy clip. We're big fans of the company's business model.
Aug 22, 2012
Dividend Growth Gem Medtronic Posts a Decent First Quarter
Medical heart-rhythm device maker Medtronic posted solid first-quarter results. The company remains an attractive dividend growth idea.
Jul 21, 2012
Strong Growth Continues At Intuitive Surgical
Surgical device maker Intuitive Surgical reported another strong quarter on Thursday.
Jun 13, 2012
Johnson and Johnson’s Deal for Synthes Closes; Healthcare Spending Will Grow
We take a look at some recent developments in the healthcare industry.
Apr 18, 2012
Intuitive Surgical Posts Strong First-Quarter Results
Intuitive Surgical continues to impress. We'd love to add the firm to the portfolio in our Best Ideas Newsletter, but only at the right price.


Latest News and Media

The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.